Navigation Links
MedQuist Announces Reseller Agreement With Clario
Date:10/13/2009

MT. LAUREL, N.J., Oct. 13 /PRNewswire-FirstCall/ -- MedQuist Inc. (Nasdaq: MEDQ), a leading provider of clinical documentation workflow technology and services, and Clario Medical Imaging Inc. announced today they have agreed to expand their existing commercial relationship, to enable MedQuist to market and resell Clario's zVision(TM) software. The current partnership has already produced the integration of zVision with MedQuist's SpeechQ for Radiology(TM) real-time speech recognition solution.

zVision aggregates information from SpeechQ, existing radiology information systems (RIS) and PACS, and other sources, then builds a database precisely customized for the radiology practice. The combined information is then presented at the radiologist's desktop in a single-view worklist format, to facilitate rapid workflow management and access to dictation using SpeechQ for Radiology.

Clario's tool is particularly powerful in radiology environments in which RIS and PACS from multiple vendors are in use, since zVision permits convenient cross-platform data interfaces. It also offers critical results reporting, ability to select cases for peer review, and data retrieval to radiologists through a unique dashboard view.

"We are delighted to collaborate with Clario -- an innovative organization with a unique understanding of the needs that radiology teams require," stated Peter Masanotti, President and CEO of MedQuist. "zVision's intelligent, feature-rich design enhances SpeechQ for Radiology to deliver all of the valuable information radiologists need in one place at one time."

MedQuist will be demonstrating this integration in its booth (#8713) at RSNA 2009 (November 29 through December 4 in Chicago).

About MedQuist

MedQuist is a leading provider of medical transcription ser
'/>"/>

SOURCE MedQuist Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Escalon(R) Announces Going Concern Qualification
2. Sangamo Announces Closing of Common Stock Offering
3. Catalyst Pharmaceutical Partners, Inc. Announces Organizational Changes and Extension of Chief Executives Employment Agreement
4. Eclipse Announces Partnership with Human Med USA, Manufacturers of Revolutionary Body-Jet(R)
5. Kendle Announces Details Regarding Third Quarter 2009 Earnings Conference Call and Webcast
6. ATS Medical Announces Receipt of CE Mark for the New ATS CryoMaze 10-S Probe
7. SAFC Pharma(R) Announces Completion of $12M Contract Manufacturing Facility Expansion in Carlsbad, Calif.
8. RSB Spine, LLC, Announces FDA Clearance for the InterPlate(R) C-Ti as an Anterior Cervical Plate
9. Sono-Tek Announces Second Quarter Results
10. Dendreon Announces Election of Ian Clark and Pedro Granadillo to Board of Directors
11. Stereotaxis Announces Underwriters Exercise of Over-Allotment Option
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2010)... , July 29 Shionogi Inc., a ... the U.S. Food and Drug Administration approval of CUVPOSA™ (glycopyrrolate), ... from chronic severe drooling associated with neurologic conditions such as ... FDA. , , ... "The FDA approval of CUVPOSA provides parents and caregivers ...
(Date:7/29/2010)... July 29 AVANIR Pharmaceuticals, Inc. ... release unaudited fiscal third quarter financial results for the ... before market open on Thursday, August 5, ... Randall Kaye , M.D., Senior Vice President and ... President, Finance, will host an investment community conference call ...
(Date:7/29/2010)... China , July 29 /PRNewswire-Asia/ -- Winner ... Company"), a leading manufacturer of medical,dressings, medical disposables and ... announced today that it opened its,first online PurCotton(R) store ... http://purcotton.mall.taobao.com/ . , ... ...
Breaking Medicine Technology:Shionogi Inc. Announces FDA Approval of CUVPOSA™ for the Treatment of Chronic Severe Drooling in Pediatric Patients With Neurologic Conditions 2Shionogi Inc. Announces FDA Approval of CUVPOSA™ for the Treatment of Chronic Severe Drooling in Pediatric Patients With Neurologic Conditions 3Shionogi Inc. Announces FDA Approval of CUVPOSA™ for the Treatment of Chronic Severe Drooling in Pediatric Patients With Neurologic Conditions 4AVANIR Pharmaceuticals Invites Investors to Fiscal 2010 Third Quarter Conference Call 2Winner Medical Launches Its First Online PurCotton(R) Store in China on Taobao.com 2Winner Medical Launches Its First Online PurCotton(R) Store in China on Taobao.com 3Winner Medical Launches Its First Online PurCotton(R) Store in China on Taobao.com 4Winner Medical Launches Its First Online PurCotton(R) Store in China on Taobao.com 5Regado Biosciences to Present at the BioPharm America 2009 Conference on September 17 2009 14051 1Regado Biosciences to Present at the BioPharm America 2009 Conference on September 17 2009 14051 2The Uptake of Novel Therapies Will Drive the Obesity Drug Market to Increase More than Six Fold to Over 243 2 Billion in 2018 57174 1The Uptake of Novel Therapies Will Drive the Obesity Drug Market to Increase More than Six Fold to Over 243 2 Billion in 2018 57174 2The Uptake of Novel Therapies Will Drive the Obesity Drug Market to Increase More than Six Fold to Over 243 2 Billion in 2018 57174 3Dr Dorin Panescu NewCardios Chief Technology Officer Awarded Professional Career Achievement Award by the IEEE Engineering in Medicine and Biology 57169 1Dr Dorin Panescu NewCardios Chief Technology Officer Awarded Professional Career Achievement Award by the IEEE Engineering in Medicine and Biology 57169 2Dr Dorin Panescu NewCardios Chief Technology Officer Awarded Professional Career Achievement Award by the IEEE Engineering in Medicine and Biology 57169 3Dr Dorin Panescu NewCardios Chief Technology Officer Awarded Professional Career Achievement Award by the IEEE Engineering in Medicine and Biology 57169 4Dr Dorin Panescu NewCardios Chief Technology Officer Awarded Professional Career Achievement Award by the IEEE Engineering in Medicine and Biology 57169 5
... validate efficacy of the processTHOUSAND OAKS, Calif., Feb. 24 ... successfully completed the initial primate trials validating the efficacy ... in spinal fusion surgery. 100% fusion was obtained ... was observed. The company is currently preparing Pre-IDE ...
... Feb. 24 BioTrends is pleased to announce the fielding of ... (R) . Takeda Pharmaceutical Company Limited announced that they ... febuxostat) on February 13, 2009. Uloric (R) ... and represents the first product for gout that has been approved ...
Other Medicine Technology:Bone Biologics Announces Significant Milestone for Spinal Fusion Surgery Using Recombinant Protein and Demineralized Bone Matrix 2
(Date:7/29/2010)... for the first time a cell-of-origin for human ... better predictive and diagnostics tools and the development ... the disease. , The researchers, from UCLA,s Jonsson ... in benign prostate tissue could become human prostate ... finding that bucks conventional wisdom. It had been ...
(Date:7/29/2010)... N.Y. -- Hockey fans likely would assume that body-checking ... causes the most injuries in youth ice hockey. But ... study, the largest and most comprehensive analysis to date ... overall injuries were caused by accidentally hitting the boards ... by a puck. , Only 34 percent of the ...
(Date:7/29/2010)... publishing the mnemonic "ABCD" to facilitate the early diagnosis ... moniker says early detection remains a key factor in ... and colleagues from the Ronald O. Perelman Department of ... that, despite all of the advances in melanoma diagnosis, ... critical. Their report appears online on CA First Look, ...
(Date:7/29/2010)... Amanda Gardner HealthDay Reporter , , WEDNESDAY, July 28 ... able to grow an entire joint from stem cells, albeit ... rabbits were able to hop and walk and bear weight, ... of a paper published online July 29 in The ... joint with restored functioning." If replicated in humans, the ...
(Date:7/29/2010)... Public immunization efforts may be much more sensitive than ... or risks of vaccination, scientists at Harvard University report ... avoidance via social networks can make the difference between ... as large. , The finding, published in Proceedings ... of the worst pertussis outbreaks in 50 years, in ...
Breaking Medicine News(10 mins):Health News:UCLA scientists for the first time identify a cell-of-origin for human prostate cancer 2Health News:UCLA scientists for the first time identify a cell-of-origin for human prostate cancer 3Health News:Most youth hockey injuries caused by accidents, not checking, UB study shows 2Health News:The evolution of melanoma diagnosis: 25 years beyond the ABCDs 2Health News:Scientists Use Stem Cells to Help Rabbits Grow New Joints 2Health News:Scientists Use Stem Cells to Help Rabbits Grow New Joints 3Health News:Small increases in vaccine cost can cause large gaps in protection 2
... Dec. 13 Robert Klaus, President and CEO ... an Outstanding,Public Advocacy Award from the Friends of ... "Robert Klaus,s contributions on behalf of oral ... country," said Peter Anas,Executive Director, NIDCR. "He has ...
... for the Hospital,s ... State-of-the-Art Cardiothoracic Center, SANTA CLARA, Calif., Dec. ... a new network,infrastructure to support a trust-wide Picture Archiving ... Hospitals, part,of the NHS Foundation Trust in Essex, United ...
... Exchange(R),(Amex(R)) today lists the common stock and units of ... QGP.U. One unit consists of three shares of,common stock, ... Warrants,(QGP.WS.B). The common stock and units will be listed ... a later date upon separation of the,unit., The ...
... The chances of infection are boosted 50-fold to 100,000-fold, study ... discovery that perplexes HIV experts, an international team reports that ... of the virus to do its damage. , According to ... , the fibers capture the virus and then ferry it ...
... shows blocking this dependence could stop disease before it ... to certain growth factors contributes to the development of ... activation of a normally silent gene, scientists say. , ... blocking this addiction might help prevent cancer growth. ...
... to see, the mammalian eye also detects light for a ... the timing of the sleep/wake cycle, which is synchronized by ... hypothalamus. , In a study published online on December ... humans whose non-visual responses to light remain intact, suggesting that ...
Other Medicine News:Health News:Oral Health America's Robert Klaus Honored for Outstanding Public Advocacy 2Health News:Extreme Networks Provides Resilient Wired and Wireless Network to the UK's Basildon & Thurrock Hospital 2Health News:Extreme Networks Provides Resilient Wired and Wireless Network to the UK's Basildon & Thurrock Hospital 3Health News:American Stock Exchange Lists the Common Stock and Units of The Quantum Group, Inc. 2Health News:Fibers in Semen Help HIV Penetrate Cells 2Health News:Cell 'Addiction' to Growth Factors May Help Spur Cancers 2Health News:Blind humans lacking rods and cones retain normal responses to non-visual effects of light 2Health News:Blind humans lacking rods and cones retain normal responses to non-visual effects of light 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: